This company listing is no longer active
BiVictriX Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
BiVictriX Therapeutics has a total shareholder equity of £2.3M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £3.0M and £676.0K respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
| Interest coverage ratio | n/a |
| Cash | UK£1.69m |
| Equity | UK£2.31m |
| Total liabilities | UK£676.00k |
| Total assets | UK£2.98m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4DE's short term assets (£2.6M) exceed its short term liabilities (£589.0K).
Long Term Liabilities: 4DE's short term assets (£2.6M) exceed its long term liabilities (£87.0K).
Debt to Equity History and Analysis
Debt Level: 4DE is debt free.
Reducing Debt: 4DE had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4DE has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 4DE has less than a year of cash runway if free cash flow continues to reduce at historical rates of 28% each year